EU approval for Teva’s quarterly dosed migraine drug 09-Apr-2019 By Maggie Lynch Teva’s anti-CGRP migraine drug lines up next to its competitors as the European Commission grants it marketing authorization.
US FDA eases Teva headache with Ajovy approval 18-Sep-2018 By Flora Southey Regulatory setbacks at Teva’s CMO facility in Korea have not halted the regulatory progression of preventive migraine treatment Ajovy, which has received US FDA approval.
